Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Aperture Investors European Innovation Fund Wins 2026 LSEG Lipper Fund Awards
-
7 Best Debt-Relief Programs That Actually Lower Payments in 2026
-
Valtin Apparel Highlights Custom Clothing Manufacturing Support for Fashion Brands and Growing Labels
-
Nonprofits Choose ezCheckprinting and Virtual Printer Combo For Best Compatibility with Latest QB Versions
-
The Rise of 'New-Collar' Hiring: Experience Overtakes Degrees, SOFTSWISS-Pentasia Report Shows
-
Geotab’s 2025 Sustainability and Impact Report shows fleets cutting fuel waste, reducing idling by up to 30%, and electrifying as energy costs rise
-
MetaComp unveils Web2.5 VisionX Engine and AgentX, Advancing the StableX Network as the Compliance Layer for Agentic Payment and Wealth (1)
-
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
-
European DataWarehouse Claims Its First “Fintech Provider of the Year” Award and a Sixth “Data Provider of the Year” Title at GlobalCapital’s 2026 European Securitisation Awards
-
Tineco Recognised as the World’s Leading Manufacturer of Wet & Dry Vacuum Cleaners for the Fourth Consecutive Year
-
Global Ride Gear Market to Reach USD 11.36 Billion by 2032, Expanding at a CAGR of 11.27% | Vyansa Intelligence
-
Mexedia Among the Leading Teams at Race for the Cure 2026
-
Vantiva - Estimated Operational Results Full Year 2025
-
China's 15th Five-Year Plan: Charting Solutions in an Uncertain World
-
Toobit Debuts P2P Marketplace with Zero Fees, Expanding Global Fiat Ecosystem
-
Vetoquinol: 2025 Annual Results
-
Bekaert - Update on the Share Buyback Program and Liquidity Agreement
-
Max Stock Limited Announces Change in Shares Held by an Interested Party
-
EP YAYING Concludes a Successful Debut at Shanghai Fashion Week MODE, Presenting Immersive Eastern Aesthetics on the Global Fashion Stage
-
Battery X Metals Announces Corporate Awareness Engagements
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - March 27
-
Viewpoint hosted by Dennis Quaid Featured American Partnership for Eosinophilic Disorders in New Educational Segment
-
Falcon Oil & Gas Ltd. - Falcon Provides Update on Transaction with Tamboran
-
Helios Consortium Offer for CAB
-
Performance Brokerage Services to Present on the State of the Automotive Buy-Sell Market at the 2026 National Association of Dealer Counsel Annual Member Conference
-
PDMR Shareholdings
-
Save the date: Kalmar’s Capital Markets Day on 2 November 2026 and Site Visit on 3 November 2026
-
Bavarian Nordic Submits Data to EMA to Extend Mpox and Smallpox Vaccine Approval to Children Aged 2-11 Years
-
Falcon Oil & Gas Ltd. - Falcon Provides Update on Transaction with Tamboran
-
Convocation of ordinary general meeting of 29 April 2026
-
NBPE Announces February Monthly NAV Estimate
-
SalMar – Integrated annual report 2025
-
NBPE Announces Transaction in Own Shares
-
ARGAN: Summary of the 2026 Combined General Meeting of Shareholders
-
Holding(s) in Company
-
Transaction in Own Shares
-
Director Appointment
-
Net Asset Value
-
JDE Peet’s transfers shares and grants awards to participants under its employee incentive plans
-
Bekaert: Transparency Law
-
Transparency notification
-
PDFtoExcelConverter.co Launches AI Tool for PDF to Excel Conversion
-
Big Feelings, Bigger Paws: Baby Barney Needs Hugs & Food by Renee Servello
-
Novaturas Announces Changes in Chief Financial Officer Position
-
DDPAI Expands North American Availability with Amazon Canada Launch
-
GenSight Biologics Reports Estimated Full-Year Consolidated Financial Results for 2025
-
3D Investment Partners Discloses materials that organize in detail the process by which the Toho HD Audit and Supervisory Committee reached its decision not to start litigation, and that point out the
-
CoreAge Rx Gains Recognition Across Multiple Independent Reviews for Its Structured, Physician-Guided Telehealth Approach to Weight Management
-
Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors
-
ABIONYX Pharma Achieves Major Milestone in apoA-I Biomanufacturing with Breakthrough in Synthetic Sphingomyelin Production
